• Explore /
  • Poster
  • / Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy.

Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy.

Abstract Poster

Authors

null

Susan F. Slovin

Memorial Sloan Kettering Cancer Center, New York, NY

Susan F. Slovin , Karen E. Knudsen , Susan Halabi , Emily Carbone , Celina Fernandez , Yu Chen , Karen A. Autio , Dana E. Rathkopf , Lewis J. Kampel , Michael J. Morris , Gabrielle Arauz , Ryon P Graf , James Kelvin , Ryan Vance Dittamore , Renee De Leeuw , Amanda Sullivan , Kin Tse , Ana M. Molina , Howard I. Scher , William Kevin Kelly

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02218606

Citation

J Clin Oncol 35, 2017 (suppl; abstr 5034)

DOI

10.1200/JCO.2017.35.15_suppl.5034

Abstract #

5034

Poster Bd #

108

Abstract Disclosures

Similar Posters

First Author: Susan F. Slovin

First Author: Carlo Buonerba

First Author: Giulio Francolini

First Author: Carlo Buonerba